Laddar...
A bone marrow toxicity model for (223)Ra alpha-emitter radiopharmaceutical therapy
PURPOSE: Ra-223, an α-particle emitting bone-seeking radionuclide, has recently been used in clinical trials for osseous metasteses of prostate cancer. We investigated the relationship between absorbed fraction-based red marrow dosimetry and cell level-dosimetry using a model that accounts for the e...
Sparad:
| Huvudupphovsmän: | , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2012
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3442928/ https://ncbi.nlm.nih.gov/pubmed/22546715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1088/0031-9155/57/10/3207 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|